OPKO finalizes Ophthalmic Technologies purchase

Article

OPKO Health has completed its acquisition of Ophthalmic Technologies Inc. (OTI), a privately owned Canadian company.

OPKO Health has completed its acquisition of Ophthalmic Technologies Inc. (OTI), a privately owned Canadian company.

OTI markets a full line of ultrasound and imaging products and its new Spectral SLO-OCT system provides confocal fundus imaging allowing for accurate point-to-point registration and orientation of the B-Scan image in real-time.

OTI's new system offers a wide range of clinical possibilities with its ability to provide high resolution B-Scan images, 3D Tomographic and Topographic data, and Optic Nerve and RNFL data for monitoring glaucoma patients.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.